| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |